AVITA Medical announced an investor webinar on August 12, 2026, where CEO Cary Vance and CFO David O’Toole will discuss the company’s Q2 2026 financial and business results. The webinar will include a Q&A session and cover recent earnings highlights, including record Q2 revenue of $21.7 million and raised 2026 revenue guidance to $86–89 million. AVITA Medical expects to achieve cash flow breakeven by Q4 2026. The event aims to keep shareholders and prospective investors informed about the company’s progress and outlook.
AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...
Interim results from the Phase 3 DASL-HiCaP trial show that adding darolutamide to standard androgen deprivation therapy (ADT) and radiation therapy reduces the risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence...
Anthropic reported a massive increase in revenue, reaching $16.3 billion in the first half of 2026 compared to just $1.1 billion in the same period last year. This surge highlights rapid growth and strong demand for its products or services. The dram...
NEAR Protocol (NEAR) experienced the largest 24-hour decline among major cryptocurrencies, falling 8.93% to $4.47. Other notable drops included Bitcoin down 1.28% to $80,495, Ether down 1.38% to $2,360.57, and XRP down 3.45% to $1.28. These declines ...
Estimates of XRP's price rally during 2017-18 vary widely, from about 62,000% to 119,000%, depending on different starting prices and measurement periods. Vandell Aljarrah of Black Swan Capitalist highlighted a 630-fold rise when XRP moved above a tr...
